Ep. 245 Understanding Keynote 689: Immunotherapy for Head & Neck Cancer with Dr. Dylan Roden and Dr. Ravi Uppaluri

39:45 | Oct 28th

While the standard for adjuvant head and neck cancer treatment hasn't changed since 2004, a new trial using perioperative pembrolizumab is forcing clinicians to rethink their entire workflow, starting...Show More